垂体卒中管理的趋势与结局:西班牙观察性多中心研究
该西班牙多中心回顾性研究纳入215例垂体卒中合并非功能性垂体腺瘤患者,比较2017年前后治疗趋势与结局。保守治疗从17%增至30.6%(OR 0.47,95%CI 0.24-0.90,P 0.02),校正后仍显著(OR 0.46,95%CI 0.22-0.89,P=0.03),但手术仍为主要选择。保守治疗者永久性精氨酸加压素缺乏风险较低,且多数出现显著肿瘤缩小。
要点
- 保守治疗比例从2017年前的17%升至2017年及以后的30.6%(OR 0.47,95%CI 0.24-0.90,P 0.02)。
- 手术在两个时期仍是最常用治疗选择,3个月结局无统计学显著差异。
- 保守治疗者永久性精氨酸加压素缺乏风险较低,89.7%出现>25%自发肿瘤缩小。
核心结论
- 尽管近年来保守管理有所增加,手术仍是主要治疗选择;保守治疗者永久性精氨酸加压素缺乏风险较低,且高比例患者出现临床显著肿瘤缩小。
研究设计与样本
- 西班牙多中心回顾性研究,纳入215例垂体卒中合并非功能性垂体腺瘤患者,中位年龄62.2岁,男性占68.4%。
主要发现
- 保守治疗从2017年前的17%增至2017年及以后的30.6%(OR 0.47,95%CI 0.24-0.90,P 0.02),校正医院、年龄和Knosp分级后仍显著(OR 0.46,95%CI 0.22-0.89,P=0.03)。
- 两个时期3个月结局无统计学显著差异。
- 手术与保守治疗相比,永久性精氨酸加压素缺乏在2017年前为0 vs 17.9%(P=0.07),2017年及以后为0 vs 16.7%(P=0.01)。
- 保守治疗患者中89.7%出现>25%自发肿瘤缩小,74.4%出现>50%肿瘤缩小。
关键数值与推荐
- 保守治疗比例从17%增至30.6%(OR 0.47,95%CI 0.24-0.90,P 0.02)。
- 校正后OR 0.46(95%CI 0.22-0.89,P=0.03)。
- 永久性精氨酸加压素缺乏:2017年前手术组0 vs 保守组17.9%(P=0.07);2017年及以后手术组0 vs 保守组16.7%(P=0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Currently, the management for pituitary apoplexy (PA) has been promoted toward a more conservative approach, particularly for patients with low-grade PA scores. Our aim was to investigate trends in PA management and compare clinical presentation, therapeutic approaches, and outcomes before and after 2017, additionally to evaluate long-term outcomes in conservatively treated patients. METHODS: Spanish multicenter, retrospective study. Statistical analyses compared clinical presentation and outcomes between periods, adjusting for confounders. RESULTS: A total of 215 patients with PA and nonfunctioning pituitary adenoma were included, with the median age of 62.2 years and 68.4% were male patients. Of which 94 (43.7%) were diagnosed before 2017 and 121 (56.3%) in 2017 or later. Conservative treatment increased from 17% before to 30.6% in the recent period (odd ratio 0.47, 95% CI 0.24-0.90, P 0.02) This trend remained significant after adjusting for hospital, age, and Knosp grade (odd ratio 0.46, 95% CI 0.22-0.89, P = .03). However, surgery remained the most frequently used therapeutic option in both periods. There were no statistically significant differences in outcomes at 3 months between periods. Surgery compared with conservative management was associated with higher permanent arginine vasopressin deficiency in both periods (0 vs 17.9%, P = .07 before 2017; 0 vs 16.7%, P = .01 after). Up to 89.7% of patients treated conservatively, presented more than 25% spontaneous tumor shrinkage, and 74.4% had more than 50% tumor reduction. CONCLUSION: Although conservative management increased in the last years, surgery remains the predominant option. Patients managed conservatively experience a lower risk of permanent arginine vasopressin deficiency, and a high proportion exhibit clinically significant tumor shrinkage over time.
引用
- Biagetti B, Cordero Asanza E, García-Feijoo P, et al. Trends and Outcomes in Pituitary Apoplexy Management: A Spanish Observational Multicenter Study. Neurosurgery. 2024. PMID: 39636106. doi:10.1227/neu.0000000000003281
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。